Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on: January 30,2024

Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on:January 30,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on: January 22,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on:January 22,2024

A new drug target identified for diseases associated with leukemia-causing virus

by Christine Yu,Pennsylvania State UniversityKDR inhibition induces autophagic/lysosomal degradation of Tax. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49737-5A team

Updated on: August 06,2024

A new drug target identified for diseases associated with leukemia-causing virus

by Christine Yu,Pennsylvania State UniversityKDR inhibition induces autophagic/lysosomal degradation of Tax. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49737-5A team

Updated on:August 06,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on: September 10,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on:September 10,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on: March 12,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on:March 12,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on: March 30,2024

Most detailed atlas to date of human blood stem cells could guide future leukemia care

byCincinnati Children's Hospital Medical CenterA large team of scientists led by experts at Cincinnati Children's has published the world's most detailed "atlas" of the man

Updated on:March 30,2024

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on: December 28,2023

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on:December 28,2023

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on: May 23,2024

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

Updated on:May 23,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on: February 24,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on:February 24,2024